Authors’ contributions {31b}
All authors have made substantial contributions to the design of the trial and read and approved the current version of the protocol. ABr, principal investigator, led the proposal and protocol development. HSS contributed to the trial design, clinical trial expertise, and writing. RC, Pakistan’s national coordinator, contributed to the trial design and clinical expertise. PM, Tanzania’s national coordinator, contributed to the trial design and clinical expertise. ABe and OO, Nigeria’s national coordinators, contributed to the trial design and clinical expertise. MA contributed to the trial design and trial management expertise. AK contributed to the trial design and clinical expertise. KJ contributed to the trial design and clinical expertise.